Antibiotic Resistance (‘ABR’) has featured heavily in the news, and has been a particular concern of the nation’s Chief Medical Officer. ABR has the potential to wipe out the future mortality/longevity improvements we might otherwise reasonably expect from general medical/lifestyle advances.
Nicola Oliver, Mortality and Longevity Consultant, Medical Intelligence (UK) Ltd, Ross Hamilton, Ross Hamilton, pensions consultant, Willis Towers Watson and Dr Craig Armstrong, Aviva Longevity Research Team
In January 2017 the IFoA set up a working party to model the likely impact of ABR. In this session, members of the working party will present their findings (including plausible future scenarios and mortality/morbidity impacts), and describe the model produced by the working party (with associated UK parameterisation).
Refreshments will be served from 17:30 and the lecture will start promptly at 18:00.
For this and all our future talks, we would like you to register online to attend because it will help us better understand and manage our attendee profile. We have also introduced a small fee of £10 for non-members to attend our talks. Attendance for our members will remain free of charge.
The booking link for this talk will be available soon.
Further details can be found at http://sias.org.uk/events/upcoming-events/
Staple Inn Hall, High Holborn, London, WC1V 7QJ
Nearest Public Transport
Chancery Lane Station